You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Smoldering multiple myeloma (SMM)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Jul 13, 2023

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Nov 17, 2023

Multiple Myeloma, Smoldering Trial in United States (Omega-3, Curcumin, Probiotic)

Recruiting
  • Multiple Myeloma, Smoldering
  • Omega-3
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 1, 2023

Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)

Recruiting
  • Prostate Cancer
  • +3 more
  • Curcumin plus Piperine
  • Rochester, New York
    University of Rochester
Jun 17, 2022

Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial in United States (Whole Foods Plant-based Diet, Algae

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
  • Whole Foods Plant-based Diet
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Plant based meals)

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Multiple Myeloma
  • Plant based meals
  • Basking Ridge, New Jersey
  • +6 more
Apr 11, 2022

Smoldering Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Daratumumab)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Tampa, Florida
  • +9 more
Jul 8, 2022

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

MGUS, SMM, and MM Patient Experience With Coronavirus 19 Survey

Recruiting
  • Multiple Myeloma
  • +3 more
  • Questionnaire
  • Lehi, Utah
    HealthTree.org (Online)
Aug 2, 2021

Multiple Myeloma Trial in Austria, Germany, Israel (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA], Placebo 1.7 ml

Active, not recruiting
  • Multiple Myeloma
  • Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
  • Placebo 1.7 ml Subcutaneous Solution
  • Graz, Austria
  • +9 more
Aug 24, 2022

Smoldering Multiple Myeloma Trial (Selinexor)

Not yet recruiting
  • Smoldering Multiple Myeloma
  • (no location specified)
Oct 27, 2022

Monoclonal Gammopathy of Undetermined Significance and

Terminated
  • Smoldering Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 4, 2021

    Smouldering Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone, Lenalidomide)

    Recruiting
    • Smouldering Myeloma
    • Brno, Czechia
    • +15 more
    Mar 22, 2022

    Smoldering Multiple Myeloma Trial in Rochester (Denosumab)

    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Rochester, New York
      University of Rochester
    Oct 3, 2022

    Smoldering Multiple Myeloma Trial in Belgium, France, Monaco (Myelogram)

    Recruiting
    • Smoldering Multiple Myeloma
    • Myelogram
    • Bruxelles, Belgium
    • +89 more
    Aug 9, 2022

    Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

    Not yet recruiting
    • Multiple Myeloma
    • Smoldering Multiple Myeloma
    • Ciltacabtagene Autoleucel
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 2, 2023

    Multiple Myeloma Trial run by the National Cancer Institute (NCI) (Dexamethasone, Carfilzomib, Daratumumab)

    Recruiting
    • Multiple Myeloma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Teclistamab, Lenalidomide,

    Recruiting
    • High-risk Smoldering Multiple Myeloma
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Aug 11, 2022

    Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance
    • Smoldering Multiple Myeloma
    • Metformin XR
    • Placebo
    • Boston, Massachusetts
    • +6 more
    Oct 3, 2022

    Smoldering Multiple Myeloma Trial in Spain (carfilzomib, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Barcelona, Spain
    • +15 more
    Feb 15, 2021

    Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

    Not yet recruiting
    • Cancer Prevention
    • +5 more
    • Prolonged Fasting Intervention
    • EDUCATION CONTROL
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 28, 2022

    Multiple Myeloma, High Risk Smoldering Multiple Myeloma Trial in United States (Ixazomib (MLN9708), Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • High Risk Smoldering Multiple Myeloma
    • Basking Ridge, New Jersey
    • +5 more
    Nov 15, 2022

    Quality of Life in Asymptomatic Monoclonal Gammopathies

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance
    • Smoldering Plasma Cell Myeloma
    • Quality-of-Life Assessment
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Smoldering Multiple Myeloma Trial in Boston (Nivolumab, Lenalidomide, Dexamethasone)

    Suspended
    • Smoldering Multiple Myeloma
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 4, 2022

    Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

    Not yet recruiting
    • Multiple Myeloma
    • Miami, Florida
      University of Miami
    Oct 20, 2023